No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ICU SeaStar Medical
- 0.3714
- +0.0052+1.42%
Close May 31 16:00 ET
- 0.3649
- -0.0065-1.75%
Post 19:57 ET
28.01MMarket Cap-431P/E (TTM)
0.3860High0.3651Low705.36KVolume0.3700Open0.3662Pre Close264.20KTurnover0.98%Turnover RatioLossP/E (Static)75.42MShares1.716952wk High-6.29P/B26.86MFloat Cap0.162052wk Low--Dividend TTM72.33MShs Float22.0000Historical High--Div YieldTTM5.71%Amplitude0.1620Historical Low0.3740Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | SeaStar MEdical Holdings Publishes Manuscript On Multiorgan Failure Patients Treated With Selective Cytopheretic Device
Express News | SeaStar Medical Holding Q1 2024 Adj EPS $(0.19) Misses $(0.15) Estimate
10-Q: Quarterly report
Express News | SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
Express News | SeaStar Medical Announces $3.6 Million Nih Grant Award to Study the Selective Cytopheretic Device in Adult Patients With Severe Chronic Heart Failure
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Super Micro Computer, Inc. (NASDAQ:SMCI) fell sharply during Friday's session.The company announced its third-quarter earnings date and did not provide preliminary estimates as it did with t
Comments
$SeaStar Medical(ICU.US$
NEWS
Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility
SeaStar Medical Holding (Nasdaq: ICU) announced the publication of a manuscript in Transplantation Direct reviewing four case studies involving their Selective Cytopheretic Device (SCD). The device demonstrated effectiveness in stabilizing and improving the clinical status of critically ill patients aged 22 months to 7...
NEWS
Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility
SeaStar Medical Holding (Nasdaq: ICU) announced the publication of a manuscript in Transplantation Direct reviewing four case studies involving their Selective Cytopheretic Device (SCD). The device demonstrated effectiveness in stabilizing and improving the clinical status of critically ill patients aged 22 months to 7...
$SeaStar Medical(ICU.US$ this is such a junk whole market rise but this junk still unable to move
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
tereche : U holding?
Jenna RaganOP tereche: yes. Holding to 1.+
just need more news
Gman511 :
